ATE264101T1 - Verwendung von thioamidoxazolidinonen zur behandlung von knochenresorption und osteoporose - Google Patents
Verwendung von thioamidoxazolidinonen zur behandlung von knochenresorption und osteoporoseInfo
- Publication number
- ATE264101T1 ATE264101T1 AT01926589T AT01926589T ATE264101T1 AT E264101 T1 ATE264101 T1 AT E264101T1 AT 01926589 T AT01926589 T AT 01926589T AT 01926589 T AT01926589 T AT 01926589T AT E264101 T1 ATE264101 T1 AT E264101T1
- Authority
- AT
- Austria
- Prior art keywords
- osteoporosis
- thioamidoxazolidinones
- bone resorption
- treat bone
- treat
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19868800P | 2000-04-20 | 2000-04-20 | |
| PCT/US2001/010805 WO2001080841A2 (en) | 2000-04-20 | 2001-04-17 | Use of thioamide oxazolidinones for the treatment of bone resorption and osteoporosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE264101T1 true ATE264101T1 (de) | 2004-04-15 |
Family
ID=22734385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01926589T ATE264101T1 (de) | 2000-04-20 | 2001-04-17 | Verwendung von thioamidoxazolidinonen zur behandlung von knochenresorption und osteoporose |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20020010341A1 (de) |
| EP (1) | EP1274426B1 (de) |
| JP (1) | JP2003531167A (de) |
| AT (1) | ATE264101T1 (de) |
| AU (2) | AU5311301A (de) |
| CA (1) | CA2405543A1 (de) |
| DE (1) | DE60102812T2 (de) |
| DK (1) | DK1274426T3 (de) |
| ES (1) | ES2218407T3 (de) |
| NZ (1) | NZ522080A (de) |
| PT (1) | PT1274426E (de) |
| TR (1) | TR200401141T4 (de) |
| WO (1) | WO2001080841A2 (de) |
| ZA (1) | ZA200208269B (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2841472B1 (fr) * | 2002-06-28 | 2006-02-24 | Agronomique Inst Nat Rech | Composition nutritionnelle ou therapeutique contenant le compose hesperidine ou l'un de ses derives |
| FR2853549B1 (fr) * | 2003-04-11 | 2007-11-09 | Agronomique Inst Nat Rech | Composition nutritionnelle ou therapeutique contenant le compose oleuropeine ou l'un de ses derives |
| EP1874782A1 (de) | 2005-04-15 | 2008-01-09 | Ranbaxy Laboratories Limited | Oxazolidinon-derivate als antimikrobielle mittel |
| CA2610978A1 (en) | 2005-06-29 | 2007-01-04 | Pharmacia & Upjohn Company Llc | Homomorpholine oxazolidinones as antibacterial agents |
| US7618989B2 (en) | 2006-08-15 | 2009-11-17 | Wyeth | Tricyclic oxazolidone derivatives useful as PR modulators |
| FR3005419B1 (fr) | 2013-05-13 | 2015-09-04 | Agronomique Inst Nat Rech | Utilisation d'une association de deux composes pour le traitement et/ou la prevention de troubles osseux |
| FR3066919B1 (fr) | 2017-06-06 | 2019-08-02 | Institut National De La Recherche Agronomique (Inra) | Composition de phycocyanine pour son utilisation pour inhiber la resorption osseuse. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0710657T3 (da) * | 1994-11-02 | 1999-05-25 | Merck Patent Gmbh | Adhæsionsreceptor-antagonister |
| DE19516483A1 (de) * | 1995-05-05 | 1996-11-07 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten |
| WO1998054161A1 (en) * | 1997-05-30 | 1998-12-03 | Pharmacia & Upjohn Company | Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
-
2001
- 2001-03-17 AU AU5311301A patent/AU5311301A/xx active Pending
- 2001-03-17 AU AU2001253113A patent/AU2001253113B2/en not_active Ceased
- 2001-04-17 TR TR2004/01141T patent/TR200401141T4/xx unknown
- 2001-04-17 EP EP01926589A patent/EP1274426B1/de not_active Expired - Lifetime
- 2001-04-17 US US09/836,804 patent/US20020010341A1/en not_active Abandoned
- 2001-04-17 WO PCT/US2001/010805 patent/WO2001080841A2/en active IP Right Grant
- 2001-04-17 DE DE60102812T patent/DE60102812T2/de not_active Expired - Fee Related
- 2001-04-17 JP JP2001577940A patent/JP2003531167A/ja active Pending
- 2001-04-17 CA CA002405543A patent/CA2405543A1/en not_active Abandoned
- 2001-04-17 AT AT01926589T patent/ATE264101T1/de not_active IP Right Cessation
- 2001-04-17 ES ES01926589T patent/ES2218407T3/es not_active Expired - Lifetime
- 2001-04-17 DK DK01926589T patent/DK1274426T3/da active
- 2001-04-17 NZ NZ522080A patent/NZ522080A/en unknown
- 2001-04-17 PT PT01926589T patent/PT1274426E/pt unknown
-
2002
- 2002-10-14 ZA ZA200208269A patent/ZA200208269B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE60102812D1 (de) | 2004-05-19 |
| AU2001253113B2 (en) | 2005-02-03 |
| JP2003531167A (ja) | 2003-10-21 |
| EP1274426A2 (de) | 2003-01-15 |
| WO2001080841A2 (en) | 2001-11-01 |
| US20020010341A1 (en) | 2002-01-24 |
| ES2218407T3 (es) | 2004-11-16 |
| EP1274426B1 (de) | 2004-04-14 |
| DK1274426T3 (da) | 2004-06-21 |
| CA2405543A1 (en) | 2001-11-01 |
| DE60102812T2 (de) | 2005-06-16 |
| TR200401141T4 (tr) | 2004-07-21 |
| AU5311301A (en) | 2001-11-07 |
| ZA200208269B (en) | 2004-02-11 |
| NZ522080A (en) | 2004-04-30 |
| WO2001080841A3 (en) | 2002-04-04 |
| PT1274426E (pt) | 2004-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE468137T1 (de) | Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten | |
| DE60223694D1 (de) | Pflaster zur behandlung von funktionsstörungen und störungen des nagelwachstums | |
| ATE251903T1 (de) | Verwendung von phosphororganischen verbindungen zur therapeutischen und prophylaktischen behandlung von infektionen | |
| DE50009504D1 (de) | Verwendung von retigabin zur behandlung von neuropathischen schmerzen | |
| DE50312145D1 (de) | Vorrichtung zur behandlung von frakturen des femur | |
| DE60114580D1 (de) | Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen | |
| DE50212701D1 (de) | Bestrahlungsanordnung zur behandlung von akne und aknenarben | |
| DE60140516D1 (de) | Behandlung von fluorkohlenstoff- ausgangsmaterialien | |
| DE60028863D1 (de) | Elektrochirurgisches Handstück zur Behandlung von Gewebe | |
| DE60317061D1 (de) | Ibandronsäure zur behandlung und vorbeugung von osteoporose | |
| DE60214542D1 (de) | Verwendung von cox2 inhibitoren zur behandlung von schizophrenia und des ticks | |
| DE69913548D1 (de) | Mglur5 antagonisten zur behandlung von schmerzen und angstzuständen | |
| DE60136477D1 (de) | Retinoide zur behandlung von emphysem | |
| DE60027209D1 (de) | Arzneimittel enthaltend hydroxyapatite zur behandlung von knochengewebserkrankungen | |
| ATE353667T1 (de) | Verwendung von proteasom-inhibitoren zur behandlung des trockenen auges | |
| DE50114605D1 (de) | No-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz | |
| ATE264101T1 (de) | Verwendung von thioamidoxazolidinonen zur behandlung von knochenresorption und osteoporose | |
| DE50105735D1 (de) | Chlorzoxazon zur behandlung von psoriasis | |
| DE60223707D1 (de) | Calcium-l-threonat zur behandlung von knochenfrakturen | |
| ATE291921T1 (de) | Verwendung von bisphosphonaten zur behandlung von osteogenese imperfecta | |
| DE60117122D1 (de) | Verwendung von mirtazapin zur behandlung von schlafstörungen | |
| DE60141979D1 (de) | Verwendung von endothelin antagonisten zur behandlung von knochenkrebs und damit verbundenen schmerzen | |
| ATE337004T1 (de) | Verwendung von mangafodipir zur behandlung der hepatozellularen insuffizienz | |
| DE60233740D1 (de) | Benzoägüchinolinderivate zur behandlung von glaucom und kurzsichtigkeit | |
| ATE302009T1 (de) | Ubichinon qn zur behandlung von migräneschmerzen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1274426 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |